Reproductive ageing in women

Journal of Pathology

Volumn 211, Issue 2, 2007, Pages 219-231

  Djahanbakhch, O ^a,b,c   Ezzati, M ^a   Zosmer, A ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Ageing; Aneuploidy; Female; Follicle; FSH; GnRH; LH; Meiosis; Obstetric; Oocyte; Perinatal

Indexed keywords

AGING; ANEUPLOIDY; CHROMOSOME ABERRATION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENETIC RISK; GERIATRIC DISORDER; GERM CELL; GYNECOLOGIC DISEASE; HIGH RISK PREGNANCY; HORMONE ACTION; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MATERNAL AGE; MATERNAL MORBIDITY; MATERNAL MORTALITY; MENOPAUSAL SYNDROME; MENSTRUAL CYCLE; NEWBORN PERIOD; ONTOGENY; OOCYTE DEVELOPMENT; OVARY FOLLICLE DEVELOPMENT; OVULATION; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SPONTANEOUS ABORTION;

ADOLESCENT; ADULT; AGING; CHILD; CHROMOSOME ABERRATIONS; FEMALE; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS, PITUITARY; HUMANS; INFANT; MATERNAL AGE; MENOPAUSE; MIDDLE AGED; NEUROSECRETORY SYSTEMS; OOCYTES; OVARIAN FOLLICLE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PUBERTY;

EID: 33846659074     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2108     Document Type: Review

References (206)

1. Franchi LL, Mandl AM, Zuckerman S. The development of the ovary and the process of oogenesis. In The Ovary, Zuckerman S (ed). Academic Press: London, 1962; 1-88.
2. Baker TG. A quantitative and cytological study of germ cells in human ovaries. Proc R Soc Lond B Biol Sci 1963;158:417-433.
3. Baker TG. Radiosensitivity of mammalian oocytes with particular reference to the human female. Am J Obstet Gynecol 1971;110(5):746-761.
4. Baker TG. Oogenesis and ovarian development. In Reproductive Biology, Balin H, Glasser S (eds). Excerpta Medica: Amsterdam, 1972; 398-437.
5. Baker TG, Sum W. Development of the ovary and oogenesis. Clin Obstet Gynaecol 1976;3(1):3-26.
6. van den Hurk R, Zhao J. Formation of mammalian oocytes and their growth, differentiation and maturation within ovarian follicles. Theriogenology 2005;63(6):1717-1751.
7. La Rosa C, Traggiai C, Stanhope R. Normal childhood, puberty and adolescence. In Paediatric and Adolescent Gynaecology, Balen AH, Creighton SM, Davies MC, MacDougall J, Stanhope R (eds). Cambridge University Press: Cambridge, 2004; 44-50.
8. Faddy MJ. Follicle dynamics during ovarian ageing. Mol Cell Endocrinol 2000;163(1-2):43-48.
9. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev 1996;17(2):121-155.
10. Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod 1986;1(2):81-87.
11. Motta PM, Makabe S. Elimination of germ cells during differentiation of the human ovary: an electron microscopic study. Eur J Obstet Gynecol Reprod Biol 1986;22(5-6):271-286.
12. Motta PM, Makabe S. Germ cells in the ovarian surface during fetal development in humans. A three-dimensional microanatomical study by scanning and transmission electron microscopy. J Submicrosc Cytol 1986;18(2):271-290.
13. Speed RM. The possible role of meiotic pairing anomalies in the atresia of human fetal oocytes. Hum Genet 1988;78(3):260-266.
14. Ratts VS, Flaws JA, Kolp R, Sorenson CM, Tilly JL. Ablation of bcl-2 gene expression decreases the numbers of oocytes and primordial follicles established in the postnatal female mouse gonad. Endocrinology 1995;136(8):3665-3668.
15. Forest MG, Sizonenko PC, Cathiard AM, Bertrand J. Hypophysogonadal function in humans during the first year of life. 1. Evidence for testicular activity in early infancy. J Clin Invest 1974;53(3):819-828.
16. Kaplan SL, Grumbach MM, Aubert ML. The ontogenesis of pituitary hormones and hypothalamic factors in the human fetus: maturation of central nervous system regulation of anterior pituitary function. Recent Prog Horm Res 1976;32:161-243.
17. Kaplan SL, Grumbach MM. The ontogenesis of human fetal hormones. II. Luteinizing hormone (LH) and follicle stimulating hormone (FSH). Acta Endocrinol (Copenh) 1976;81(4):808-829.
18. Reiter EO, Grumbach MM. Neuroendocrine control mechanisms and the onset of puberty. Annu Rev Physiol 1982;44:595-613.
19. Terasawa E, Fernandez DL. Neurobiological mechanisms of the onset of puberty in primates. Endocr Rev 2001;22(1):111-151.
20. Waldhauser F, Weissenbacher G, Frisch H, Pollak A. Pulsatile secretion of gonadotropins in early infancy. Eur J Pediatr 1981;137(1):71-74.
21. Grumbach MM, Styne DM. Puberty: ontogeny, neuroendocrinology, physiology, and disorders. In Williams Textbook of Endocrinology, Wilson JD, Foster DW, Kronenberg HM, Larsen PR (eds). Saunders: Philadelphia, PA, 1998; 1509-1625.
22. Grumbach MM, Kaplan SL. The neuroendocrinology of human puberty: an ontogenetic perspective. In Control of the Onset of Puberty, Grumbach MM, Sizonenko PC, Aubert ML (eds). Williams & Wilkins: Baltimore, MD, 1990; 1-62.
23. Terasawa E, Fernandez DL. Neurobiological mechanisms of the onset of puberty in primates. Endocr Rev 2001;22(1):111-151.
24. El Majdoubi M, Sahu A, Ramaswamy S, Plant TM. Neuropeptide Y: a hypothalamic brake restraining the onset of puberty in primates. Proc Natl Acad Sci USA 2000;97(11):6179-6184.
25. Ebling FJ. The neuroendocrine timing of puberty. Reproduction 2005;129(6):675-683.
26. Grumbach MM. The neuroendocrinology of human puberty revisited. Horm Res 2002;57:(suppl 2):2-14.
27. Winter JS, Faiman C, Hobson WC, Prasad AV, Reyes FI. Pituitary-gonadal relations in infancy. I. Patterns of serum gonadotropin concentrations from birth to four years of age in man and chimpanzee. J Clin Endocrinol Metab 1975;40(4):545-551.
28. Keen KL, Burich AJ, Mitsushima D, Kasuya E, Terasawa E. Effects of pulsatile infusion of the GABA(A) receptor blocker bicuculline on the onset of puberty in female rhesus monkeys. Endocrinology 1999;140(11):5257-5266.
29. Mitsushima D, Marzban F, Luchansky LL, Burich AJ, Keen KL, Durning M, et al. Role of glutamic acid decarboxylase in the prepubertal inhibition of the luteinizing hormone releasing hormone release in female rhesus monkeys. J Neurosci 1996;16(8):2563-2573.
30. Mitsushima D, Hei DL, Terasawa E. Gamma-aminobutyric acid is an inhibitory neurotransmitter restricting the release of luteinizing hormone-releasing hormone before the onset of puberty. Proc Natl Acad Sci USA 1994;91(1):395-399.
31. Kasuya E, Nyberg CL, Mogi K, Terasawa E. A role of gamma-amino butyric acid (GABA) and glutamate in control of puberty in female rhesus monkeys: effect of an antisense oligodeoxynucleotide for GAD67 messenger ribonucleic acid and MK801 on luteinizing hormone-releasing hormone release. Endocrinology 1999;140(2):705-712.
32. Gore AC, Mitsushima D, Terasawa E. A possible role of neuropeptide Y in the control of the onset of puberty in female rhesus monkeys. Neuroendocrinology 1993;58(1):23-34.
33. Plant TM, Gay VL, Marshall GR, Arslan M. Puberty in monkeys is triggered by chemical stimulation of the hypothalamus. Proc Nutl Acad Sci USA 1989;86(7):2506-2510.
34. Mahachoklertwattana P, Sanchez J, Kaplan SL, Grumbach MM. N-methyl-D-aspartate (NMDA) receptors mediate the release of gonadotropin-releasing hormone (GnRH) by NMDA in a hypothalamic GnRH neuronal cell line (GTI-1). Endocrinology 1994;134(3):1023-1030.
35. Bettendorf M, de Zegher F, Albers N, Hart CS, Kaplan SL, Grumbach MM. Acute N-methyl-D,L-aspartate administration stimulates the luteinizing hormone releasing hormone pulse generator in the ovine fetus. Horm Res 1999;51(1):25-30.
36. Boyar RM, Rosenfeld RS, Kapen S, Finkelstein JW, Roffwarg HP, Weitzman ED, et al. Human puberty. Simultaneous augmented secretion of luteinizing hormone and testosterone during sleep. J Clin Invest 1974;54(3):609-618.
37. Boyar RM, Wu RH, Roffwarg H, Kapen S, Weitzman ED, Hellman L, et al. Human puberty: 24-hour estradiol in pubertal girls. J Clin Endocrinol Metab 1976;43(6):1418-1421.
38. Yen SS, Apter D, Butzow T, Laughlin GA. Gonadotrophin releasing hormone pulse generator activity before and during sexual maturation in girls: new insights. Hum Reprod 1993;8:(suppl 2):66-71.
39. Apter D, Butzow TL, Laughlin GA, Yen SS. Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins. J Clin Endocrinol Metab 1993;76(4):940-949.
40. Stanhope R, Brook CG. An evaluation of hormonal changes at puberty in man. J Endocrinol 1988;116(2):301-305.
41. Padmanabhan V, McNeilly AS. Is there an FSH-releasing factor? Reproduction 2001;121(1):21-30.
42. r 32 000 protein with inhibin activity from porcine follicular fluid. Proc Natl Acad Sci USA 1985;82(21):7217-7221.
43. Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M, et al. Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature 1986;321(6072):779-782.
44. Vale W, Rivier J, Vaughan J, McClintock R, Corrigan A, Woo W, et al. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 1986;321(6072):776-779.
45. Ueno N, Ling N, Ying SY, Esch F, Shimasaki S, Guillemin R. Isolation and partial characterization of follistatin: a single-chain Mr 35000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc Natl Acad Sci USA 1987;84(23):8282-8286.
46. Foster CM, Olton PR, Racine MS, Phillips DJ, Padmanabhan V. Sex differences in FSH-regulatory peptides in pubertal age boys and girls and effects of sex steroid treatment. Hum Reprod 2004;19(7):1668-1676.
47. Sehested A, Juul AA, Andersson AM, Petersen JH, Jensen TK, Muller J, et al. Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels. J Clin Endocrinol Metab 2000;85(4):1634-1640.
48. Luisi S, Lombardi I, Florio P, Cobellis L, Iughetti L, Bernasconi S, et al. Serum activin A levels in males and females during pubertal development. Gynecol Endocrinol 2001;15(1):1-4.
49. Elsholz DD, Padmanabhan V, Rosenfield RL, Olton PR, Phillips DJ, Foster CM. GnRH agonist stimulation of the pituitary-gonadal axis in children: age and sex differences in circulating inhibin-B and activin-A. Hum Reprod 2004;19(12):2748-2758.
50. Foster CM, Olton PR, Padmanabhan V. Diurnal changes in FSH-regulatory peptides and their relationship to gonadotrophins in pubertal girls. Hum Reprod 2005;20(2):543-548.
51. Foster CM, Phillips DJ, Wyman T, Evans LW, Groome NP, Padmanabhan V. Changes in serum inhibin, activin and follistatin concentrations during puberty in girls. Hum Reprod 2000;15(5):1052-1057.
52. Young IM, Francis PL, Leone AM, Stovell P, Silman RE. Constant pineal output and increasing body mass account for declining melatonin levels during human growth and sexual maturation. J Pineal Res 1988;5(1):71-85.
53. Karsch FJ, Bittman EL, Foster DL, Goodman RL, Legan SJ, Robinson JE. Neuroendocrine basis of seasonal reproduction. Recent Prog Horm Res 1984;40:185-232.
54. Kadva A, Djahanbakhch O, Monson J, Di WL, Silman R. Elevated nocturnal melatonin is a consequence of gonadotropin-releasing hormone deficiency in women with hypothalamic amenorrhea. J Clin Endocrinol Metab 1998;83(10):3653-3662.
55. Cheung CC, Thornton JE, Nurani SD, Clifton DK, Steiner RA. A reassessment of leptin's role in triggering the onset of puberty in the rat and mouse. Neuroendocrinology 2001;74(1):12-21.
56. Ozata M, Ozdemir IC, Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 1999;84(10):3686-3695.
57. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392(6674):398-401.
58. Backstrom CT, McNeilly AS, Leask RM, Baird DT. Pulsatile secretion of LH, FSH, prolactin, oestradiol and progesterone during the human menstrual cycle. Clin Endocrinol (Oxf) 1982;17(1):29-42.
59. Yen SS, Lasley BL, Wang CF, Leblanc H, Siler TM. The operating characteristics of the hypothalamic-pituitary system during the menstrual cycle and observations of biological action of somatostatin. Recent Prog Horm Res 1975;31:321-363.
60. Knobil E, Plant TM, Wildt L, Belchetz PE, Marshall G. Control of the rhesus monkey menstrual cycle: permissive role of hypothalamic gonadotropin-releasing hormone. Science 1980;207(4437):1371-1373.
61. Knobil E. The neuroendocrine control of the menstrual cycle. Recent Prog Horm Res 1980;36:53-88.
62. Gallo RV. Pulsatile LH release during the ovulatory LH surge on proestrus in the rat. Biol Reprod 1981;24(1):100-104.
63. Djahanbakhch O, Warner P, McNeilly AS, Baird DT. Pulsatile release of LH and oestradiol during the periovulatory period in women. Clin Endocrinol (Oxf) 1984;20(5):579-589.
64. Edwards RG. Test-tube babies, 1981. Nature 1981;293(5830): 253-256.
65. Testart J, Frydman R, Roger M. Seasonal influence of diurnal rhythms in the onset of the plasma luteinizing hormone surge in women. J Clin Endocrinol Metab 1982;55(2):374-377.
66. Djahanbakhch O, McNeilly AS, Hobson BM, Templeton AA. A rapid luteinizing hormone radioimmunoassay for the prediction of ovulation. Br J Obstet Gynaecol 1981;88(10):1016-1020.
67. Boyar R, Finkelstein J, Roffwarg H, Kapen S, Weitzman E, Hellman L. Synchronization of augmented luteinizing hormone secretion with sleep during puberty. N Engl J Med 1972;287(12):582-586.
68. Djahanbakhch O, McNeilly AS, Warner PM, Swanston IA, Baird DT. Changes in plasma levels of prolactin, in relation to those of FSH, oestradiol, androstenedione and progesterone around the pre-ovulatory surge of LH in women. Clin Endocrinol (Oxf) 1984;20(4):463-472.
69. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44(235):291-303.
70. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001;76(5):874-878.
71. Sherman BM, West JH, Korenman SG. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 1976;42(4):629-636.
72. Lee SJ, Lenton EA, Sexton L, Cooke ID. The effect of age on the cyclical patterns of plasma LH, FSH, oestradiol and progesterone in women with regular menstrual cycles. Hum Reprod 1988;3(7):851-855.
73. Burger HG, Dudley EC, Robertson DM, Dennerstein L. Hormonal changes in the menopause transition. Recent Prog Horm Res 2002;57:257-275.
74. Burger HG, Cahir N, Robertson DM, Groome NP, Dudley E, Green A, et al. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin Endocrinol (Oxf) 1998;48(6):809-813.
75. Burger HG, Dudley EC, Hopper JL, Groome N, Guthrie JR, Green A, et al. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 1999;84(11):4025-4030.
76. Klein NA, Illingworth PJ, Groome NP, McNeilly AS, Battaglia DE, Soules MR. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 1996;81(7):2742-2745.
77. Klein NA, Houmard BS, Hansen KR, Woodruff TK, Sluss PM, Bremner WJ, et al. Age-related analysis of inhibin A, inhibin B, and activin a relative to the intercycle monotropic follicle-stimulating hormone rise in normal ovulatory women. J Clin Endocrinol Metab 2004;89(6):2977-2981.
78. Danforth DR, Arbogast LK, Mroueh J, Kim MH, Kennard EA, Seifer DB, et al. Dimeric inhibin: a direct marker of ovarian aging. Fertil Steril 1998;70(1):119-123.
79. Santoro N, Adel T, Skurnick JH. Decreased inhibin tone and increased activin A secretion characterize reproductive aging in women. Fertil Steril 1999;71(4):658-662.
80. Reame NE, Wyman TL, Phillips DJ, de Kretser DM, Padmanabhan V. Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin A may contribute in part to the rise in follicular phase follicle-stimulating hormone of aging cycling women. J Clin Endocrinol Metab 1998;83(9):3302-3307.
81. Hurwitz JM, Santoro N. Inhibins, activins, and follistatin in the aging female and male. Semin Reprod Med 2004;22(3):209-217.
82. Burger HG, Cahir N, Robertson DM, Groome NP, Dudley E, Green A, et al. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin Endocrinol (Oxf) 1998;48(6):809-813.
83. Burger HG, Dudley EC, Hopper JL, Groome N, Guthrie JR, Green A, et al. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 1999;84(11):4025-4030.
84. Tong S, Wallace EM, Burger HG. Inhibins and activins: clinical advances in reproductive medicine. Clin Endocrinol (Oxf) 2003;58(2):115-127.
85. Schwall RH, Mason AJ, Wilcox JN, Bassett SG, Zeleznik AJ. Localization of inhibin/activin subunit mRNAs within the primate ovary. Mol Endocrinol 1990;4(1):75-79.
86. Yamoto M, Minami S, Nakano R, Kobayashi M. Immunohistochemical localization of inhibin/activin subunits in human ovarian follicles during the menstrual cycle. J Clin Endocrinol Metab 1992;74(5):989-993.
87. Roberts VJ, Barth S, el-Roeiy A, Yen SS. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J Clin Endocrinol Metab 1993;77(5):1402-1410.
88. Landgren BM, Collins A, Csemiczky G, Burger HG, Baksheev L, Robertson DM. Menopause transition: annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause. J Clin Endocrinol Metab 2004;89(6):2763-2769.
89. Overlie I, Morkrid L, Andersson AM, Skakkebaek NE, Moen MH, Holte A. Inhibin A and B as markers of menopause: a five-year prospective longitudinal study of hormonal changes during the menopausal transition. Acta Obstet Gynecol Scand 2005;84(3):281-285.
90. Klein NA, Battaglia DE, Woodruff TK, Padmanabhan V, Giudice LC, Bremner WJ, et al. Ovarian follicular concentrations of activin, follistatin, inhibin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-2 (IGFBP-2), IGFBP-3, and vascular endothelial growth factor in spontaneous menstrual cycles of normal women of advanced reproductive age. J Clin Endocrinol Metab 2000;85(12):4520-4525.
91. Hansen KR, Thyer AC, Sluss PM, Bremner WJ, Soules MR, Klein NA. Reproductive ageing and ovarian function: is the early follicular phase FSH rise necessary to maintain adequate secretory function in older ovulatory women? Hum Reprod 2005;20(1):89-95.
92. van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 2005;83(4):979-987.
93. Gruijters MJ, Visser JA, Durlinger AL, Themmen AP. Anti-Mullerian hormone and its role in ovarian function. Mol Cell Endocrinol 2003;211(1-2):85-90.
94. Rey R, Sabourin JC, Venara M, Long WQ, Jaubert F, Zeller WP, et al. Anti-Mullerian hormone is a specific marker of sertoli-and granulosa-cell origin in gonadal tumors. Hum Pathol 2000;31(10):1202-1208.
95. Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction 2002;124(5):601-609.
96. Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 2002;77(3):468-471.
97. Fanchin R, Schonauer LM, Righini C, Guibourdenche J, Frydman R, Taieb J. Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 2003;18(2):323-327.
98. Davison SL, Bell R, Donath S, Montalto JG, Davis Sr. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005;90(7):3847-3853.
99. Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000;85(8):2832-2838.
100. Abdalla HI, Baber R, Kirkland A, Leonard T, Power M, Studd JW. A report on 100 cycles of oocyte donation; factors affecting the outcome. Hum Reprod 1990;5(8):1018-1022.
101. Abdalla HI, Burton G, Kirkland A, Johnson MR, Leonard T, Brooks AA, et al. Age, pregnancy and miscarriage: uterine versus ovarian factors. Hum Reprod 1993;8(9):1512-1517.
102. Sauer MV, Paulson RJ, Lobo RA. A preliminary report on oocyte donation extending reproductive potential to women over 40. N Engl J Med 1990;323(17):1157-1160.
103. Navot D, Bergh PA, Williams MA, Garrisi GJ, Guzman I, Sandler B, et al. Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility. Lancet 1991;337(8754):1375-1377.
104. Baird DT, Collins J, Egozcue J, Evers LH, Gianaroli L, Leridon H, et al; ESHRE Capri Workshop Group. Fertility and ageing. Hum Reprod Update 2005;11(3):261-276.
105. Speroff L. The effect of aging on fertility. Curr Opin Obstet Gynecol 1994;6(2):115-120.
106. Cano F, Simon C, Remohi J, Pellicer A. Effect of aging on the female reproductive system: evidence for a role of uterine senescence in the decline in female fecundity. Fertil Steril 1995;64(3):584-589.
107. de la Rochebrochard E, Thonneau P. Paternal age and maternal age are risk factors for miscarriage; results of a multicentre European study. Hum Reprod 2002;17(6):1649-1656.
108. Hassold TJ, Jacobs PA. Trisomy in man. Annu Rev Genet. 1984;18:69-97.
109. Sherman SL, Freeman SB, Allen EG, Lamb NE. Risk factors for non-disjunction of trisomy 21. Cytogenet Genome Res 2005;111(3-4):273-280.
110. McFadden DE, Friedman JM. Chromosome abnormalities in human beings. Mutat Res 1997;396(1-2):129-140.
111. Kamiguchi Y, Rosenbusch B, Sterzik K, Mikamo K. Chromosomal analysis of unfertilized human oocytes prepared by a gradual fixation-air drying method. Hum Genet 1993;90(5):533-541.
112. Veiga A, Calderon G, Santalo J, Barri PN, Egozcue J. Chromosome studies in oocytes and zygotes from an IVF programme. Hum Reprod 1987;2(5):425-430.
113. Dailey T, Dale B, Cohen J, Munne S. Association between non-disjunction and maternal age in meiosis-II human oocytes. Am J Hum Genet 1996;59(1):176-184.
114. Mahmood R, Brierley CH, Faed MJ, Mills JA, Delhanty JD. Mechanisms of maternal aneuploidy: FISH analysis of oocytes and polar bodies in patients undergoing assisted conception. Hum Genet 2000;106(6):620-626.
115. Clyde JM, Gosden RG, Rutherford AJ, Picton HM. Demonstration of a mechanism of aneuploidy in human oocytes using Multifluor fluorescence in situ hybridization. Fertil Steril 2001;76(4):837-840.
116. Sandalinas M, Marquez C, Munne S. Spectral karyotyping of fresh, non-inseminated oocytes. Mol Hum Reprod 2002;8(6):580-585.
117. Pellestor F, Andreo B, Anahory T, Hamamah S. The occurrence of aneuploidy in human: lessons from the cytogenetic studies of human oocytes. Eur J Med Genet 2006;49(2):103-116.
118. Pellestor F, Anahory T, Hamamah S. Effect of maternal age on the frequency of cytogenetic abnormalities in human oocytes. Cytogenet Genome Res 2005;111(3-4):206-212.
119. Pellestor F, Andreo B, Arnal F, Humeau C, Demaille J. Maternal aging and chromosomal abnormalities: new data drawn from in vitro unfertilized human oocytes. Hum Genet 2003;112(2):195-203.
120. Nicolaidis P, Petersen MB. Origin and mechanisms of non-disjunction in human autosomal trisomies. Hum Reprod 1998;13(2):313-319.
121. Battaglia DE, Goodwin P, Klein NA, Soules MR. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Hum Reprod 1996;11(10):2217-2222.
122. Hassold T, Abruzzo M, Adkins K, Griffin D, Merrill M, Millie E, et al. Human aneuploidy: incidence, origin, and etiology. Environ Mol Mutagen 1996;28(3):167-175.
123. MacDonald M, Hassold T, Harvey J, Wang LH, Morton NE, Jacobs P. The origin of 47,XXY and 47,XXX aneuploidy: heterogeneous mechanisms and role of aberrant recombination. Hum Mol Genet 1994;3(8):1365-1371.
124. Abruzzo MA, Hassold TJ. Etiology of non-disjunction in humans. Environ Mol Mutagen 1995;25:(suppl 26):38-47.
125. Warburton D. The effect of maternal age on the frequency of trisomy: change in meiosis or in utero selection? Prog Clin Biol Res 1989;311:165-181.
126. Warburton D. Human female meiosis: new insights into an error-prone process. Am J Hum Genet 1997;61(1):1-4.
127. Eichenlaub-Ritter U, Boll I. Nocodazole sensitivity, age-related aneuploidy, and alterations in the cell cycle during maturation of mouse oocytes. Cytogenet Cell Genet 1989;52(3-4):170-176.
128. Eichenlaub-Ritter U, Stahl A, Luciani JM. The microtubular cytoskeleton and chromosomes of unfertilized human oocytes aged in vitro. Hum Genet 1988;80(3):259-264.
129. Gaulden ME. Maternal age effect: the enigma of Down syndrome and other trisomic conditions. Mutat Res 1992;296(1-2):69-88.
130. Wolstenholme J, Angell RR. Maternal age and trisomy - a unifying mechanism of formation. Chromosoma 2000;109(7): 435-438.
131. Watanabe Y, Nurse P. Cohesin Rec8 is required for reductional chromosome segregation at meiosis. Nature 1999;400(6743): 461-464.
132. Angell RR. Predivision in human oocytes at meiosis I: a mechanism for trisomy formation in man. Hum Genet 1991;86(4):383-387.
133. Angell R. Mechanism of chromosome non-disjunction in human oocytes. Prog Clin Biol Res 1995;393:13-26.
134. Angell R. First-meiotic-division non-disjunction in human oocytes. Am J Hum Genet 1997;61(1):23-32.
135. Birch-Machin MA. The role of mitochondria in ageing and carcinogenesis. Clin Exp Dermatol 2006;31(4):548-552.
136. Schapira AH. Mitochondrial disease. Lancet 2006;368(9529): 70-82.
137. Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006;125(7):1241-1252.
138. Terman A. Catabolic insufficiency and aging. Ann N Y Acad Sci 2006;1067:27-36.
139. Raftopoulou M. Mitochondrial wrinkles: the first signs of ageing? Nat Cell Biol 2005;7(9):853.
140. Lenaz G, Bovina C, D'Aurelio M, Fato R, Formiggini G, Genova ML, et al. Role of mitochondria in oxidative stress and aging. Ann N Y Acad Sci 2002;959:199-213.
141. Lenaz G. Role of mitochondria in oxidative stress and ageing. Biochim Biophys Acta 1998;1366(1-2):53-67.
142. Biesalski HK. Free radical theory of aging. Curr Opin Clin Nutr Metab Care 2002;5(1):5-10.
143. Wilding M, Di Matteo L, Dale B. The maternal age effect: a hypothesis based on oxidative phosphorylation. Zygote 2005;13(4):317-323.
144. Bartmann AK, Romao GS, Ramos Eda S, Ferriani RA. Why do older women have poor implantation rates? A possible role of the mitochondria. J Assist Reprod Genet 2004;21(3):79-83.
145. Eichenlaub-Ritter U, Vogt E, Yin H, Gosden R. Spindles, mitochondria and redox potential in ageing oocytes. Reprod Biomed Online 2004;8(1):45-58.
146. Schon EA, Kim SH, Ferreira JC, Magalhaes P, Grace M, Warburton D, et al. Chromosomal non-disjunction in human oocytes: is there a mitochondrial connection? Hum Reprod 2000;15:(suppl 2):160-172.
147. Tarin JJ. Potential effects of age-associated oxidative stress on mammalian oocytes/embryos. Mol Hum Reprod 1996;2(10): 717-724.
148. Linnane AW, Zhang C, Baumer A, Nagley P. Mitochondrial DNA mutation and the ageing process: bioenergy and pharmacological intervention. Mutat Res 1992;275(3-6):195-208.
149. Keefe DL, Niven-Fairchild T, Powell S, Buradagunta S. Mitochondrial deoxyribonucleic acid deletions in oocytes and reproductive aging in women. Fertil Steril 1995;64(3):577-583.
150. Zhang X, Wu XQ, Lu S, Guo YL, Ma X. Deficit of mitochondria-derived ATP during oxidative stress impairs mouse MII oocyte spindles. Cell Res 2006;[Epub ahead of print].
151. Keefe DL, Marquard K, Liu L. The telomere theory of reproductive senescence in women. Curr Opin Obstet Gynecol 2006;18(3):280-285.
152. Blasco MA, Gasser SM, Lingner J. Telomeres and telomerase. Genes Dev 1999;13(18):2353-2359.
153. Greider CW. Telomeres, telomerase and senescence. Bioessays 1990;12(8):363-369.
154. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345(6274):458-460.
155. von Zglinicki T, Saretzki G, Docke W, Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res 1995;220(1):186-193.
156. Blackburn EH, Greider CW, Henderson E, Lee MS, Shampay J, Shippen-Lentz D. Recognition and elongation of telomeres by telomerase. Genome 1989;31(2):553-560.
157. Yu GL, Blackburn EH. Developmentally programmed healing of chromosomes by telomerase in Tetrahymena. Cell 1991;67(4):823-832.
158. Harrington LA, Greider CW. Telomerase primer specificity and chromosome healing. Nature 1991;353(6343):451-454.
159. Collins K. Structure and function of telomerase. Curr Opin Cell Biol 1996;8(3):374-380.
160. de Lange T. Ending up with the right partner. Nature 1998;392(6678):753-754.
161. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996;18(2):173-179.
162. Wright DL, Jones EL, Mayer JF, Oehninger S, Gibbons WE, Lanzendorf SE. Characterization of telomerase activity in the human oocyte and preimplantation embryo. Mol Hum Reprod 2001;7(10):947-955.
163. Joseph KS, Allen AC, Dodds L, Turner LA, Scott H, Liston R. The perinatal effects of delayed childbearing. Obstet Gynecol 2005;105(6):1410-1418.
164. Jacobsson B, Ladfors L, Milsom I. Advanced maternal age and adverse perinatal outcome. Obstet Gynecol 2004;104(4):727-733.
165. Cnattingius S, Forman MR, Berendes HW, Isotalo L. Delayed childbearing and risk of adverse perinatal outcome. A population-based study. J Am Med Assoc 1992;268(7):886-890.
166. Salihu HM, Shumpert MN, Slay M, Kirby RS, Alexander GR. Childbearing beyond maternal age 50 and fetal outcomes in the United States. Obstet Gynecol 2003;102:1006-1014.
167. Cleary-Goldman J, Malone FD, Vidaver J, Ball RH, Nyberg DA, Comstock CH, et al; FASTER Consortium. Impact of maternal age on obstetric outcome. Obstet Gynecol 2005;105:983-990.
168. Gilbert WM, Nesbitt TS, Danielsen B. Childbearing beyond age 40: pregnancy outcome in 24032 cases. Obstet Gynecol 1999;93(1):9-14.
169. Berkowitz GS, Skovron ML, Lapinski RH, Berkowitz RL. Delayed childbearing and the outcome of pregnancy. N Engl J Med 1990;322(10):659-664.
170. Bianco A, Stone J, Lynch L, Lapinski R, Berkowitz G, Berkowitz RL. Pregnancy outcome at age 40 and older. Obstet Gynecol. 1996;87(6):917-922.
171. Lin HC, Sheen TC, Tang CH, Kao S. Association between maternal age and the likelihood of a cesarean section: a population-based multivariate logistic regression analysis. Acta Obstet Gynecol Scand 2004;83(12):1178-1183.
172. Peipert JF, Bracken MB. Maternal age: an independent risk factor for cesarean delivery. Obstet Gynecol 1993;81:200-205.
173. Dulitzki M, Soriano D, Schiff E, Chetrit A, Mashiach S, Seidman DS. Effect of very advanced maternal age on pregnancy outcome and rate of cesarean delivery. Obstet Gynecol 1998;92:935-939.
174. Dildy GA, Jackson GM, Fowers GK, Oshiro BT, Varner MW, Clark SL. Very advanced maternal age: pregnancy after age 45. Am J Obstet Gynecol 1996;175:668-674.
175. Lialios G, Kaponis A, Adonakis G. Maternal age as an independent risk factor for cesarean delivery. Int J Gynaecol Obstet 1999;67:187-188.
176. Ecker JL, Chen KT, Cohen AP, Riley LE, Lieberman ES. Increased risk of cesarean delivery with advancing maternal age: indications and associated factors in nulliparous women. Am J Obstet Gynecol 2001;185:883-887.
177. Sheffer-Mimouni G, Mashiach S, Dor J, Levran D, Seidman DS. Factors influencing the obstetric and perinatal outcome after oocyte donation. Hum Reprod 2002;17(10):2636-2640.
178. Abdalla HI, Billett A, Kan AK, Baig S, Wren M, Korea L, et al. Obstetric outcome in 232 ovum donation pregnancies. Br J Obstet Gynaecol 1998;105(3):332-337.
179. Israel SL, Deutschberger J. Relation of the mother's age to obstetric performance. Obstet Gynecol 1964;24:411-417.
180. Kane SH. Advancing age and the primigravida. Obstet Gynecol 1967;29(3):409-414.
181. Morrison I. The elderly primigravida. Am J Obstet Gynecol 1975;121(4):465-470.
182. Hansen JP. Older maternal age and pregnancy outcome: a review of the literature. Obstet Gynecol Surv 1986;41(11):726-742.
183. Forman MR, Meirik O, Berendes HW. Delayed childbearing in Sweden. J Am Med Assoc 1984;252(22):3135-3139.
184. Aldous MB, Edmonson MB. Maternal age at first childbirth and risk of low birth weight and preterm delivery in Washington State. J Am Med Assoc 1993;270(21):2574-2577.
185. Cnattingius S, Berendes HW, Forman MR. Do delayed child-bearers face increased risks of adverse pregnancy outcomes after the first birth? Obstet Gynecol 1993;81(4):512-516.
186. Fretts RC, Schmittdiel J, McLean FH, Usher RH, Goldman MB. Increased maternal age and the risk of fetal death. N Engl J Med 1995;333(15):953-957.
187. Naeye RL. Maternal age, obstetric complications, and the outcome of pregnancy. Obstet Gynecol 1983;61(2):210-216.
188. Fretts RC. Etiology and prevention of stillbirth. Am J Obstet Gynecol 2005;193(6):1923-1935.
189. Norwitz ER, Edusa V, Park JS. Maternal physiology and complications of multiple pregnancy. Semin Perinatol 2005;29(5):338-348.
190. Rand L, Eddleman KA, Stone J. Long-term outcomes in multiple gestations. Clin Perinatol 2005;32(2):495-513.
191. Rao A, Sairam S, Shehata H. Obstetric complications of twin pregnancies. Best Pract Res Clin Obstet Gynaecol 2004;18(4):557-576.
192. Smith-Levitin M, Skupski DW, Chervenak FA. Multifetal pregnancies. Curr Opin Obstet Gynecol 1995;7(6):465-471.
193. Lambalk CB, De Koning CH, Braat DD. The endocrinology of dizygotic twinning in the human. Mol Cell Endocrinol 1998;145(1-2):97-102.
194. Reynolds MA, Schieve LA, Martin JA, Jeng G, Macaluso M. Trends in multiple births conceived using assisted reproductive technology, United States, 1997-2000. Pediatrics 2003;111(5):part 2):1159-1162.
195. Cunningham FG, Leveno KJ. Childbearing among older women - the message is cautiously optimistic. N Engl J Med 1995;333(15):1002-1004.
196. Pearl R, Schoppe WF. Studies on the physiology of reproduction in the domestic fowl. J Exp Zool 1921;34:101-118.
197. Zuckerman S. The number of oocytes in the mature ovary. Recent Prog Horm Res 1951;6:63-108.
198. Borum K. Oogenesis in the mouse. A study of meiotic prophase. Exp Cell Res 1961;24:495-507.
199. Peters H. Migration of gonocytes into the mammalian gonad and their differentiation. Phil Trans R Soc Lond B 1970;259:91-101.
200. McLaren A. Meiosis and differentiation of mouse germ cells. Symp Soc Exp Biol 1984;38:7-23.
201. Anderson LD, Hirshfield AN. An overview of follicular development in the ovary: from embryo to the fertilized ovum in vitro. Md Med 1992;41:614-620.
202. Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germinal stem cells and follicular renewal in the postnatal mammalian ovary. Nature 2004;428:145-150.
203. Johnson J, Bagley J, Skaznik-Wikiel M, Lee HJ, Adams GB, Niikura Y, et al. Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell 2005;122:303-315.
204. Bukovsky A, Caudle MR, Svetlikova M, Upadhyaya NB. Origin of germ cells and formation of new primary follicles in adult human ovaries. Reprod Biol Endocrinol 2004;2:20.
205. Bukovsky A, Svetikova M, Caudle MR. Oogenesis in cultures derived from adult human ovaries. Reprod Biol Endocrinol 2005;3(1):17.
206. Telfer EE, Gosden RG, Byskov AG, Spears N, Albertini D, Anderson CY, et al. On regenerating the ovary and generating controversy. Cell 2005;122:821-822 [letter].